M.Sc

Centre for Aromatic Plants was established by Government of Uttarakhand in 2003 at industrial area Selaqui, Dehradun. CAP is a complete business incubator centre for the development of the aromatic sector in Uttarakhand. It is equipped with end to end facilities and support services like survey, training, research, production of quality planting material, extension, distillation and marketing etc. The focus is to make these all facilities available to the farmers, entrepreneurs, researcher, buyers, distillers, perfumers and traders under one roof.

The Institute, founded in 1946 as the Maharashtra Association for the Cultivation of Science Research Institute, was renamed in 1992 as the Agharkar Research Institute (ARI) in honour and memory of the Founder Director, the late Professor Dr. Shankar Purushottam Agharkar. The ARI is an autonomous research institution fully funded by the Department of science and Technology (DST) government of India, since 1966. It operates under the overall umbrella of the Maharashtra Association for the Cultivation of Science (MACS).

Regional Centre for Biotechnology (RCB) is an institution of national importance and statutory body established by the Department of Biotechnology, Govt. of India with regional and global partnerships synergizing with the programmes of UNESCO as a Category II Centre. The primary focus of RCB is to provide world class education, training and conduct innovative research at the interface of multiple disciplines to create high quality human resource in disciplinary and interdisciplinary areas of biotechnology in a globally competitive research milieu.

UMEDICA is a manufacturer and exporter of Pharmaceutical Formulations viz; Injectable, Tablets, Capsules, Suspensions, Dry Syrups, etc. Since our inception in 1982, we have established ourselves as a company delivering products meeting international quality standards.

UMEDICA LABORATORIES invites dedicated, passionate & competent young professionals to be part of our USFDA, EU GMP and TGA Australia approved formulations manufacturing plant UMEDICA LABORATORIES at VAPI, GUJARAT for following requirement

Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India. Intas success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades.

Navitas Life Sciences is a technology-backed global clinical research organization, with over 1500 employees spread across 6 countries.  Navitas provides end-to-end services and solutions for Life Sciences. We help our clients address their drug development needs by bringing together the capabilities of a full-service CRO, a technology-led life sciences services provider across clinical, regulatory and safety, and a life sciences big data services and analytics provider.

Springer Nature opens the doors to discovery for researchers, educators, clinicians and other professionals. Every day, around the globe, our imprints, books, journals, platforms and technology solutions reach millions of people.

Located in Cherlapally, Hyderabad, India, Sunrise International Labs Ltd is a 100 percent wholly owned subsidiary of Perdaman Pharmaceuticals Pvt Ltd, a company that specialise in the manufacture and export of various pharmaceutical product formulations such as tablets, capsules, liquid orals and sachets. Established in 1993,  Sunrise International Labs Ltd is well known for its expertise in drug delivery systems, and has continued to expand its varied product portfolio over the decades, covering a wide range of therapeutic segments.